Here, by utilizing high-throughput RNA-Seq-based screening and the related reports on CD97 promotes EMT and metastasis of ovarian cancer cells by activating the JAK2/STAT3 pathway 14, we found that the prometastatic factor CD97 could be a critical mediator of IL-8-induced promotion of EMT. Here, JAK2 is linked to ovarian carcinoma.